U.S. Global Investors (USGI)’s Idexx Laboratories IDXX Stock Holding History

U.S. Global Investors (USGI)’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-3,625	Closed	-$1.2M	–	173
2020 Q2	$1.2M	Buy	3,625 +900	+33%	+$261K	0.11%	57
2020 Q1	$660K	Sell	2,725 -3,210	-54%	-$838K	0.18%	59
2019 Q4	$1.55M	Sell	5,935 -660	-10%	-$174K	0.7%	42
2019 Q3	$1.79M	Buy	+6,595	New	+$1.84M	0.97%	28
2018 Q2	–	Sell	-12,400	Closed	-$2.37M	–	147
2018 Q1	$2.37M	Buy	+12,400	New	+$2.29M	1.46%	16
2017 Q2	–	Sell	-13,434	Closed	-$2.08K	–	163
2017 Q1	$2.08K	Sell	13,434 -4,800	-26%	-$662K	﹤0.01%	28
2016 Q4	$2.14M	Buy	18,234 +4,000	+28%	+$456K	0.9%	23
2016 Q3	$1.6M	Hold	14,234	–	–	0.76%	33
2016 Q2	$1.32M	Buy	14,234 +4,000	+39%	+$344K	0.73%	41
2016 Q1	$802K	Buy	+10,234	New	+$737K	0.43%	75

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

U.S. Global Investors (USGI)'s IDXX Position: Q3 2020 in Review

U.S. Global Investors (USGI) sold out of Idexx Laboratories (IDXX) in Q3 2020, closing a stake of 3,625 shares — an estimated $1.2M sold.

U.S. Global Investors (USGI) first reported a position in IDXX in Q1 2016 and held it in 10 quarters. The position peaked at $2.37M in Q1 2018. 846 funds tracked by Wall St. Rank hold IDXX as of Q3 2020.

U.S. Global Investors (USGI) reported no remaining Idexx Laboratories position as of Q3 2020 after selling out during the quarter.
U.S. Global Investors (USGI) sold 3,625 Idexx Laboratories shares in Q3 2020, an estimated $1.2M.
U.S. Global Investors (USGI) first reported a position in Idexx Laboratories in Q1 2016 and held it in 10 quarters.
U.S. Global Investors (USGI)'s Idexx Laboratories position peaked at $2.37M in Q1 2018.
846 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2020.

Based on U.S. Global Investors (USGI)'s 13F filing for Q3 2020, filed 13 Nov 2020.